UNSPSC 51422003: Sermorelin acetate

This classification denotes a growth hormone-releasing hormone analogue with the molecular formula C149H246N44O42S.C2H4O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00IBG87IQW, chemically known as 29-l-argininamide-30-de-l-glutamine-31-de-l-glutamine-32-deglycine-33-de-l-glutamic acid-34-de-l-serine-35-de-l-asparagine-36-de-l-glutamine-37-de-l-glutamic acid-38-de-l-arginine-39-deglycine-40-de-l-alanine-41-de-l-arginine-42-de-l-alanine-43-de-l-arginine-44-de-l-leucinamidegrowth hormone-releasing factor (human pancreatic islet), acetate (salt), hydrate but generally known as sermorelin acetate, which bears US NIH Compound Identifier 16132412.

UNSPSC 51422003 Sermorelin acetate is a Commodity code that, based on recent state and local procurement activity, shows limited alignment between the code's nominal pharmaceutical scope and actual buying patterns. The single recent opportunity posted under this code is Seminole County, Florida's IFB 60459723LAS, soliciting naloxone and safe drug deactivation systems — products unrelated to sermorelin acetate, a synthetic growth hormone-releasing hormone analog used in clinical endocrinology. The mismatch suggests either a coding error in the county's procurement system or a data tagging anomaly rather than genuine market activity in sermorelin procurement at the state and local level.

Seminole County, a Florida county government, is the sole issuing body represented in recent opportunities under this code. The IFB, posted June 30, 2026, with a response deadline of July 26, 2023, seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option and is potentially funded through FEMA. Bidders must comply with drug-free workplace certification, E-Verify requirements, and specified insurance coverage. The code shows no other recent state or local opportunities, indicating minimal or no genuine sermorelin acetate procurement activity at the state and local government level during the current solicitation window.